Bay Colony Advisors’s BioNTech BNTX Stock Holding History

Bay Colony Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,218	Closed	-$201K	–	329
2022 Q2	$201K	Buy	+1,218	New	+$186K	0.05%	318
2022 Q1	–	Sell	-1,176	Closed	-$303K	–	368
2021 Q4	$303K	Buy	1,176 +230	+24%	+$63K	0.09%	264
2021 Q3	$258K	Hold	946	–	–	0.08%	284
2021 Q2	$212K	Buy	+946	New	+$178K	0.07%	323

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bay Colony Advisors's BNTX Position: Q3 2022 in Review

Bay Colony Advisors sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 1,218 shares — an estimated $201K sold.

Bay Colony Advisors first reported a position in BNTX in Q2 2021 and held it in 4 quarters. The position peaked at $303K in Q4 2021. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

Bay Colony Advisors reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
Bay Colony Advisors sold 1,218 BioNTech shares in Q3 2022, an estimated $201K.
Bay Colony Advisors first reported a position in BioNTech in Q2 2021 and held it in 4 quarters.
Bay Colony Advisors's BioNTech position peaked at $303K in Q4 2021.
264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Bay Colony Advisors's 13F filing for Q3 2022, filed 27 Oct 2022.